Minimisation of the viral contamination risk of heterologous immunoglobulins in the context of the requirements of the State Pharmacopoeia of the Russian Federation
- DOI
- 10.30895/2221-996x-2022-22-2-112-123
- Published
- 2022-06-02
- Container
- Biological Products. Prevention, Diagnosis, Treatment
- Publisher
- SCEEMP
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.30895/2221-996x-2022-22-2-112-123,
title = {Minimisation of the viral contamination risk of heterologous immunoglobulins in the context of the requirements of the State Pharmacopoeia of the Russian Federation},
author = {V. V. Mashin and A. N. Sergeev and N. N. Martynova and T. V. Antipina and E. I. Sakanyan and V. V. Kataeva and N. V. Zagidullin},
year = {2022},
journal = {Biological Products. Prevention, Diagnosis, Treatment},
doi = {10.30895/2221-996x-2022-22-2-112-123},
url = {https://doi.org/10.30895/2221-996x-2022-22-2-112-123}
}RIS
TY - JOUR TI - Minimisation of the viral contamination risk of heterologous immunoglobulins in the context of the requirements of the State Pharmacopoeia of the Russian Federation AU - V. V. Mashin AU - A. N. Sergeev AU - N. N. Martynova AU - T. V. Antipina AU - E. I. Sakanyan AU - V. V. Kataeva AU - N. V. Zagidullin PY - 2022 JO - Biological Products. Prevention, Diagnosis, Treatment DO - 10.30895/2221-996x-2022-22-2-112-123 UR - https://doi.org/10.30895/2221-996x-2022-22-2-112-123 ER -
APA
Mashin, V. V., Sergeev, A. N., Martynova, N. N., Antipina, T. V., Sakanyan, E. I., Kataeva, V. V., & Zagidullin, N. V. (2022). Minimisation of the viral contamination risk of heterologous immunoglobulins in the context of the requirements of the State Pharmacopoeia of the Russian Federation. Biological Products. Prevention, Diagnosis, Treatment. https://doi.org/10.30895/2221-996x-2022-22-2-112-123
Source records
- crossref · retrieved 2026-09-27T10:07:45.471Z